[CAS NO. ] B4GALT1 Protein, Human (HEK293, Y285L, His)

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS

Catalog

HY-P7628

Brand

MCE

CAS

DESCRIPTION

Overview

MDL	-
Molecular Weight	50-60 kDa
Molecular Formula	-
SMILES	-

For research use only. We do not sell to patients.

Summary

B4GALT1 Protein, Human (HEK293 His) is responsible for the overcoming multidrug resistance in human leukemia therapy via regulating the activity of the hedgehog signaling pathway ^[1] ^[2] .

Appearance

Solution

Source

HEK293

Shipping

Shipping with dry ice.

References

[1] Huyang Xie, et al. Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma. Oncotarget. 2016 May 31;7(22):32723-30.
[2] Huimin Zhou, et al. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line. IUBMB Life. 2012 Nov;64(11):889-900.
[3] Claudia De Vitis, et al. B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells. J Clin Med. 2019 Nov 9;8(11):1928.